Pheton Holdings Ltd Class A Ordinary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTHL research report →
About the company
Pheton Holdings Ltd is a specialized healthcare enterprise focused on the development and commercialization of software and devices integral to brachytherapy treatments. At the core of its offerings is a proprietary treatment planning system, a sophisticated form of radiation therapy. This system facilitates the internal placement of radioactive sources within cancer patients, a process designed to eradicate malignant cells and reduce tumor size.
- CEO
- Jianfei Zhang
- IPO
- 2024
- Employees
- 10
- HQ
- Beijing, CN
Price Chart
- Market Cap
- $4.09M
- P/E
- -0.95
- P/S
- 5.47
- P/B
- 0.84
- EV/EBITDA
- -0.30
- Div Yield
- 0.00%
- Gross Margin
- 62.59%
- Op Margin
- -991.71%
- Net Margin
- -974.68%
- ROE
- -93.93%
- ROIC
- -59.10%
- Revenue
- $448.20K · -28.70%
- Net Income
- $-661,000 · -174.03%
- EPS
- $-0.05 · -212.65%
- Op Income
- $-770,000
- FCF YoY
- -1119.22%
- 52W High
- $32.00
- 52W Low
- $0.28
- 50D MA
- $0.53
- 200D MA
- $4.94
- Beta
- 5.33
- Avg Volume
- 1.36M
Get TickerSpark's AI analysis on PTHL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PTHL coverage
Recent articles, reports, and earnings notes.
No research on PTHL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PTHL report →Similar companies
Peers in the same neighborhood.